234 related articles for article (PubMed ID: 16393697)
1. Cross-regulation of JAK and Src kinases.
Ingley E; Klinken SP
Growth Factors; 2006 Mar; 24(1):89-95. PubMed ID: 16393697
[TBL] [Abstract][Full Text] [Related]
2. IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled.
Reddy EP; Korapati A; Chaturvedi P; Rane S
Oncogene; 2000 May; 19(21):2532-47. PubMed ID: 10851052
[TBL] [Abstract][Full Text] [Related]
3. JAKs, STATs and Src kinases in hematopoiesis.
Rane SG; Reddy EP
Oncogene; 2002 May; 21(21):3334-58. PubMed ID: 12032773
[TBL] [Abstract][Full Text] [Related]
4. The role of Janus kinases in haemopoiesis and haematological malignancy.
Khwaja A
Br J Haematol; 2006 Aug; 134(4):366-84. PubMed ID: 16822289
[TBL] [Abstract][Full Text] [Related]
5. Differential role of Janus family kinases (JAKs) in interferon-gamma-induced lung epithelial ICAM-1 expression: involving protein interactions between JAKs, phospholipase Cgamma, c-Src, and STAT1.
Chang YJ; Holtzman MJ; Chen CC
Mol Pharmacol; 2004 Mar; 65(3):589-98. PubMed ID: 14978237
[TBL] [Abstract][Full Text] [Related]
6. Janus kinases in cytokine signalling.
Ihle JN
Philos Trans R Soc Lond B Biol Sci; 1996 Feb; 351(1336):159-66. PubMed ID: 8650262
[TBL] [Abstract][Full Text] [Related]
7. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
[TBL] [Abstract][Full Text] [Related]
8. Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases.
Paukku K; Valgeirsdóttir S; Saharinen P; Bergman M; Heldin CH; Silvennoinen O
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):759-66. PubMed ID: 10642538
[TBL] [Abstract][Full Text] [Related]
9. The Janus protein tyrosine kinases in hematopoietic cytokine signaling.
Ihle JN
Semin Immunol; 1995 Aug; 7(4):247-54. PubMed ID: 8520029
[TBL] [Abstract][Full Text] [Related]
10. JAK/STAT signal transduction: regulators and implication in hematological malignancies.
Valentino L; Pierre J
Biochem Pharmacol; 2006 Mar; 71(6):713-21. PubMed ID: 16426581
[TBL] [Abstract][Full Text] [Related]
11. Activation of the JAK-STAT signal transduction pathway by oncostatin-M cultured human and mouse osteoblastic cells.
Levy JB; Schindler C; Raz R; Levy DE; Baron R; Horowitz MC
Endocrinology; 1996 Apr; 137(4):1159-65. PubMed ID: 8625884
[TBL] [Abstract][Full Text] [Related]
12. A new protein containing an SH2 domain that inhibits JAK kinases.
Endo TA; Masuhara M; Yokouchi M; Suzuki R; Sakamoto H; Mitsui K; Matsumoto A; Tanimura S; Ohtsubo M; Misawa H; Miyazaki T; Leonor N; Taniguchi T; Fujita T; Kanakura Y; Komiya S; Yoshimura A
Nature; 1997 Jun; 387(6636):921-4. PubMed ID: 9202126
[TBL] [Abstract][Full Text] [Related]
13. Jaks and Stats in signaling by the cytokine receptor superfamily.
Ihle JN; Kerr IM
Trends Genet; 1995 Feb; 11(2):69-74. PubMed ID: 7716810
[TBL] [Abstract][Full Text] [Related]
14. Dissociation of the Jak kinase pathway from G-CSF receptor signaling in neutrophils.
Avalos BR; Parker JM; Ware DA; Hunter MG; Sibert KA; Druker BJ
Exp Hematol; 1997 Feb; 25(2):160-8. PubMed ID: 9015216
[TBL] [Abstract][Full Text] [Related]
15. Jaks and cytokine receptors--an intimate relationship.
Haan C; Kreis S; Margue C; Behrmann I
Biochem Pharmacol; 2006 Nov; 72(11):1538-46. PubMed ID: 16750817
[TBL] [Abstract][Full Text] [Related]
16. The Jak-STAT pathway stimulated by interferon gamma.
Horvath CM
Sci STKE; 2004 Nov; 2004(260):tr8. PubMed ID: 15561980
[TBL] [Abstract][Full Text] [Related]
17. JAK protein kinase inhibitors.
Thompson JE
Drug News Perspect; 2005 Jun; 18(5):305-10. PubMed ID: 16193102
[TBL] [Abstract][Full Text] [Related]
18. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT.
Fujitani Y; Hibi M; Fukada T; Takahashi-Tezuka M; Yoshida H; Yamaguchi T; Sugiyama K; Yamanaka Y; Nakajima K; Hirano T
Oncogene; 1997 Feb; 14(7):751-61. PubMed ID: 9047382
[TBL] [Abstract][Full Text] [Related]
19. CXCL12 signaling is independent of Jak2 and Jak3.
Moriguchi M; Hissong BD; Gadina M; Yamaoka K; Tiffany HL; Murphy PM; Candotti F; O'Shea JJ
J Biol Chem; 2005 Apr; 280(17):17408-14. PubMed ID: 15611059
[TBL] [Abstract][Full Text] [Related]
20. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.
Neilson LM; Zhu J; Xie J; Malabarba MG; Sakamoto K; Wagner KU; Kirken RA; Rui H
Mol Endocrinol; 2007 Sep; 21(9):2218-32. PubMed ID: 17550976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
